Xanodyne's drug for menstrual bleeding gains FDA approval
The FDA approved Xanodyne Pharmaceuticals' Lysteda as a treatment for heavy menstrual bleeding. The agency cautioned patients about using the product in combination with hormonal contraceptives because of a high risk of blood clots, stroke and heart attack.
MSNBC
| 11/13
This story published in FMI Pharmacy dailyLead on 11/16/2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|